These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 32541092)

  • 41. MicroRNA-93 promotes cell growth and invasion in nasopharyngeal carcinoma by targeting disabled homolog-2.
    Xu YF; Mao YP; Li YQ; Ren XY; He QM; Tang XR; Sun Y; Liu N; Ma J
    Cancer Lett; 2015 Jul; 363(2):146-55. PubMed ID: 25892549
    [TBL] [Abstract][Full Text] [Related]  

  • 42. MicroRNA-215 promoted the progression of nasopharyngeal carcinoma through targeting RB1 and activating Wnt/β-catenin pathway.
    Zhang Y; Zhang H; Li X
    J BUON; 2020; 25(3):1579-1586. PubMed ID: 32862607
    [TBL] [Abstract][Full Text] [Related]  

  • 43. LINC00240 knockdown inhibits nasopharyngeal carcinoma progress by targeting miR-26a-5p.
    Chen X; Wu G; Qing J; Li C; Chen X; Shen J
    J Clin Lab Anal; 2022 May; 36(5):e24424. PubMed ID: 35421264
    [TBL] [Abstract][Full Text] [Related]  

  • 44. MiR-1178-3p promotes the proliferation, migration and invasion of nasopharyngeal carcinoma Sune-1 cells by targeting STK4.
    Wang LQ; Deng AC; Zhao L; Li Q; Wang M; Zhang Y
    J Biol Regul Homeost Agents; 2019; 33(2):321-330. PubMed ID: 30972994
    [TBL] [Abstract][Full Text] [Related]  

  • 45. MiR-30a-5p inhibits proliferation, migration and invasion of nasopharyngeal carcinoma cells by targeting NUCB2.
    Li M; Wang Y; Zhao Q; Ma W; Liu J
    Hum Exp Toxicol; 2021 Aug; 40(8):1274-1285. PubMed ID: 33567921
    [TBL] [Abstract][Full Text] [Related]  

  • 46. miR-29a/b enhances cell migration and invasion in nasopharyngeal carcinoma progression by regulating SPARC and COL3A1 gene expression.
    Qiu F; Sun R; Deng N; Guo T; Cao Y; Yu Y; Wang X; Zou B; Zhang S; Jing T; Ling T; Xie J; Zhang Q
    PLoS One; 2015; 10(3):e0120969. PubMed ID: 25786138
    [TBL] [Abstract][Full Text] [Related]  

  • 47. MicroRNA-192 promotes the development of nasopharyngeal carcinoma through targeting RB1 and activating PI3K/AKT pathway.
    Huang Q; Hou S; Zhu X; Liu S
    World J Surg Oncol; 2020 Feb; 18(1):29. PubMed ID: 32013999
    [TBL] [Abstract][Full Text] [Related]  

  • 48. CircSOX9 acts as a molecular sponge of miR-485-3p to promote the progression of nasopharyngeal carcinoma.
    Sun Y; Liu Y; Du Z; Zhou L; Chen Q; Chu H
    Aging (Albany NY); 2022 Jun; 14(11):4914-4926. PubMed ID: 35700516
    [TBL] [Abstract][Full Text] [Related]  

  • 49. MicroRNA-326 inhibits cell proliferative capacity and invasiveness through inhibiting the expression of ETS1 in nasopharyngeal carcinoma.
    Zhao X; Zhang XJ; Li L; Xia ST; Cheng L
    Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):181-188. PubMed ID: 31957831
    [TBL] [Abstract][Full Text] [Related]  

  • 50. CircZNF609 promotes cell proliferation, migration, invasion, and glycolysis in nasopharyngeal carcinoma through regulating HRAS via miR-338-3p.
    Liu Z; Liu F; Wang F; Yang X; Guo W
    Mol Cell Biochem; 2021 Jan; 476(1):175-186. PubMed ID: 32970285
    [TBL] [Abstract][Full Text] [Related]  

  • 51. MiR-203a-3p suppresses cell proliferation and metastasis through inhibiting LASP1 in nasopharyngeal carcinoma.
    Jiang N; Jiang X; Chen Z; Song X; Wu L; Zong D; Song D; Yin L; Wang D; Chen C; Bian X; He X
    J Exp Clin Cancer Res; 2017 Oct; 36(1):138. PubMed ID: 28982387
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Down-regulation of miR-1181 indicates a dismal prognosis for nasopharyngeal carcinoma and promoted cell proliferation and metastasis by modulating Wnt/β-catenin signaling.
    Hua X; Fan KC
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1077-1086. PubMed ID: 30779075
    [TBL] [Abstract][Full Text] [Related]  

  • 53. miR-184 Inhibits Tumor Invasion, Migration and Metastasis in Nasopharyngeal Carcinoma by Targeting Notch2.
    Zhu HM; Jiang XS; Li HZ; Qian LX; Du MY; Lu ZW; Wu J; Tian XK; Fei Q; He X; Yin L
    Cell Physiol Biochem; 2018; 49(4):1564-1576. PubMed ID: 30223264
    [TBL] [Abstract][Full Text] [Related]  

  • 54. MicroRNA-185 inhibits cell proliferation while promoting apoptosis and autophagy through negative regulation of TGF-β1/mTOR axis and HOXC6 in nasopharyngeal carcinoma.
    Cheng JZ; Chen JJ; Wang ZG; Yu D
    Cancer Biomark; 2018; 23(1):107-123. PubMed ID: 29991129
    [TBL] [Abstract][Full Text] [Related]  

  • 55. MiR-145, a microRNA targeting ADAM17, inhibits the invasion and migration of nasopharyngeal carcinoma cells.
    Wu J; Yin L; Jiang N; Guo WJ; Gu JJ; Chen M; Xia YY; Wu JZ; Chen D; Wu JF; Wang DJ; Zong D; Zhang N; Ding K; Huang T; He X
    Exp Cell Res; 2015 Nov; 338(2):232-8. PubMed ID: 26297956
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Novel long non-coding RNA lncAMPC downregulates PTEN via miR-214 to promote nasopharyngeal carcinoma progression.
    Li X; Ouyang S
    Mol Cell Biochem; 2022 Mar; 477(3):805-814. PubMed ID: 35059924
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The effects of microRNA-98 inhibits cell proliferation and invasion by targeting STAT3 in nasopharyngeal carcinoma.
    Liu J; Chen W; Chen Z; Wen J; Yu H; Wang F; Wu L; He X
    Biomed Pharmacother; 2017 Sep; 93():869-878. PubMed ID: 28724212
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hsa_circ_001193 regulates proliferation and apoptosis of nasopharyngeal carcinoma cells through targeting mir-496.
    Ke KJ; Wang CY; Li P; Huang XW; Zhang SL; Li X; Cui XF
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):3069-3076. PubMed ID: 32271424
    [TBL] [Abstract][Full Text] [Related]  

  • 59. miR-21 inhibitor suppresses proliferation and migration of nasopharyngeal carcinoma cells through down-regulation of BCL2 expression.
    Li Y; Yan L; Zhang W; Wang H; Chen W; Hu N; Ou H
    Int J Clin Exp Pathol; 2014; 7(6):3478-87. PubMed ID: 25031780
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Long noncoding RNA cytoskeleton regulator RNA promotes cell invasion and metastasis by titrating miR-613 to regulate ANXA2 in nasopharyngeal carcinoma.
    Chen W; Du M; Hu X; Ma H; Zhang E; Wang T; Yin L; He X; Hu Z
    Cancer Med; 2020 Feb; 9(3):1209-1219. PubMed ID: 31859457
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.